Home > PS Ratio > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
PS (Price/Sales) Ratio

The Current P/S Ratio of MEDICAMEN BIOTECH is 3.22.

Share Price ₹433.2Apr 23,2024
Market Cap ₹550.1 Cr
Sales-TTM₹170.7 CrTTM-Consolidated Results
Price/Sales3.22xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of MEDICAMEN BIOTECH

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of MEDICAMEN BIOTECH is calculated as :

Current Market Cap [ ₹550.1 Cr] as on Apr 23,2024

(/) Sales [ ₹170.7 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 3.22x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for MEDICAMEN BIOTECH , the investors are currently willing to pay '3.22 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of MEDICAMEN BIOTECH !

The chart below summarizes the trend in P/S Ratio of MEDICAMEN BIOTECH over the last five years.

Historical PS (Price/Sales) ratio chart of MEDICAMEN BIOTECH


PS Ratio Performance Analysis for MEDICAMEN BIOTECH

- MEDICAMEN BIOTECH 's latest p/e ratio is 3.22x.

- MEDICAMEN BIOTECH 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 4.98x.

- MEDICAMEN BIOTECH 's operated at median p/e ratio of 5.79x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MEDICAMEN BIOTECH 's p/e ratio peaked in Mar2022 at 6.81x.

- MEDICAMEN BIOTECH 's p/e ratio hit its five-year low in Mar2020 of 1.76x.


How does MEDICAMEN BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
MEDICAMEN BIOTECH 170.73.22550.1
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.50356,001.0
CIPLA LTD25,350.24.29108,813.0
DR REDDYS LABORATORIES LTD27,212.53.6599,325.3
ZYDUS LIFESCIENCES LTD19,024.25.0896,553.2
DIVIS LABORATORIES LTD7,492.813.36100,075.0
MANKIND PHARMA LTD9,946.39.6495,896.9
TORRENT PHARMACEUTICALS LTD10,474.08.5289,224.4
LUPIN LTD19,480.13.7072,033.6
AUROBINDO PHARMA LTD27,894.72.3064,043.1
ABBOTT INDIA LTD5,753.49.5154,704.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MEDICAMEN BIOTECH 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.30x
Max industry PS 13.36x
Median industry PS 5.08x
Average industry PS 6.43x



You may also like the below Video Courses